A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

Background: Colorectal cancer is one of the most commonly diagnosed types of cancer worldwide. An early diagnosis and detection of colon cancer and polyp can reduce mortality and morbidity from colorectal cancer. Even though there are a variety of options in screen- ing tests, the question remains on which test is the most effective for the early detection of colorectal cancer. In this prospective study, we aimed to develop a simple, useful, effective, and reliable scoring system to detect colon polyp and colorectal cancer. Methods: We enrolled 6508 subjects over the age of 18 from 16 centers, with colonoscopy screening. The age, smoking status, alcohol consumption, body mass index, polyp incidence, polyp size, number and localization, and pathologic findings were recorded. Results: The age, male gender, obesity, smoking, and family history were found as independent risk factors for adenomatous polyp. We have developed a new scoring system which can be used for these factors. With a score of 4 or above, we found the following: sensitivity 81%, specificity 40%, positive predictive value 25.68%, and negative predictive value 89.84%, for adenomatous polyp detection; and sensitivity 96%, specificity 39%, positive predictive value 3.35%, negative predictive value 99.29%, for colorectal cancer detection. Conclusion: Even though the first colorectal cancer screening worldwide is generally performed for individuals over 50 years of age, we recommend that screening for colorectal cancer might begin for those under 50 years of age as well. Individuals with a score ≥ 4 must be included in the screening tests for colorectal cancer


1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Epidemiology of colorectal cancer: incidence, mortality, sur- vival, and risk factors. Gut. 2017;66(4):683-691. [CrossRef]

2. Loomans-Kropp HA, Umar A. Increasing incidence of colorectal cancer in young adults. J Cancer Epidemiol. 2019;2019:9841295. [CrossRef]

3. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177-193. [CrossRef]

4. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age- related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150(1):17-22. [CrossRef].

5. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc. 2014;89(2):216-224. [CrossRef]

6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal can- cer. Lancet. 1996;348(9040):1472-1477. [CrossRef]

7. Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8(2):117-130. [CrossRef]

8.Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colo- noscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357(14):1403-1412. [CrossRef]

9. Ahlquist DA. Multi-target stool DNA test: a new high bar for non- invasive screening. Dig Dis Sci. 2015;60(3):623-633. [CrossRef]

10. Kirkegaard H, Johnsen NF, Christensen J, Frederiksen K, Over- vad K, Tjønneland A. Association of adherence to lifestyle recom- mendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ. 2010;341:c5504. [CrossRef]

11. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumu- lative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009;170(7):863-872. [CrossRef]

12. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281. [CrossRef]

13. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screen- ing: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017;86(1):18-33. [CrossRef]

14. Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah population database. J Natl Cancer Inst. 1994;86(21):1618-1626. [CrossRef]

15. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992-3003. [CrossRef]

16. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle colon cancer family registry. Cancer. 2011;117(21):4948-4957. [CrossRef]

17. Alsheridah N, Akhtar S. Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study. BMC Cancer. 2018;18(1):1227. [CrossRef]

18. Zhou H, Shen Z, Zhao J, Zhou Z, Xu Y. Distribution characteristics and risk factors of colorectal adenomas. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(6):678-684.

19. Yang Z, Wei X, Pan Y, Min Z, Xu J, Yu B. Colon cancer combined with obesity indicates improved survival-research on relevant mech- anism. Aging. 2020;12(23):23778-23794. [CrossRef]

20. Nam GE, Baek SJ, Choi HB, et al. Association between abdominal obesity and incident colorectal cancer: a nationwide cohort study in Korea. Cancers. 2020;12(6):1368. [CrossRef]

21. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933-947. [CrossRef]

22. Sălăgeanu A, Tucureanu C, Lerescu L, et al. Serum levels of adi- pokines resistin and leptin in patients with colon cancer. J Med Life. 2010;3(4):416-420.

23. Sanford NN, Giovannucci EL, Ahn C, Dee EC, Mahal BA. Obesity and younger versus older onset colorectal cancer in the United States, 1998-2017. J Gastrointest Oncol. 2020;11(1):121-126. [CrossRef]

24.Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000;92(22):1831-1836. [CrossRef]

25. Chia VM, Newcomb PA, Bigler J, Morimoto LM, Thibodeau SN, Potter JD. Risk of microsatellite-unstable colorectal cancer is associ- ated jointly with smoking and nonsteroidal anti-inflammatory drug use. Cancer Res. 2006;66(13):6877-6883. [CrossRef]

26. Eaton AM, Sandler R, Carethers JM, Millikan RC, Galanko J, Keku TO. 5,10-Methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):2023-2029. [CrossRef]

27. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, Samow- itz W. Dietary intake and microsatellite instability in colon tumors. Int J Cancer. 2001;93(4):601-607. [CrossRef]

28. Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236-1241. [CrossRef]

29. Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal can- cer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology. 2019;157(1):137-148. [CrossRef]

30. Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014; 63(7):1112-1119. [CrossRef]

31. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12(3):478-485. [CrossRef]


Turkish Journal of Gastroenterology
  • ISSN: 1300-4948
  • Yayın Aralığı: Yılda 12 Sayı
  • Başlangıç: 1996
  • Yayıncı: AVES Yayıncılık


Sayıdaki Diğer Makaleler

Effectiveness and Power of Abdominal Ultrasonography in the Assessment of Crohn’s Disease Activity: Comparison with Clinical, Endoscopic, and CT Enterography Findings

Betül YİĞİT, Orhan SEZGİN, Elif YORULMAZ, Mehmet Şükrü ERTÜRK, Umut ERDEM, Uğur YANÇ, Gamze Bilik OYMAN, Hatice YORULMAZ

A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

Levent ERDEM, Erdem AKBAL, Erdem KOÇAK, Dilek TUCER, Enver ÜÇBİLEK, Ahmet UYANIKOĞLU, Can DOLAPÇIOĞLU, Emel Ahısalı ERİM, Göktuğ ŞİRİN, Hüseyin ALKIM, Aliye SOYLU, Levent DOĞANAY, Ahmet Kemal KÜRBÜZ, Kamil ÖZDİL, Hakan ALAGÖZLÜ, Tuba Erürker ÖZTÜRK, Mesut SEZİKLİ, Gupse ADALI, Mehmet ÇOBAN, Saadettin HÜLAGÜ, Halil DEĞE

A Rare Complication of ERCP

Volkan GÖKBULUT, Bülent ÖDEMİŞ, Ömer ÖZTÜRK, Bülent YAMAK, İlyas TENLİK, Selcen Yüsra ABAYL, Handan ÖZTÜRK

Analysis of Esophageal Motility and Reflux Characteristics in Patients with Gastroesophageal Reflux Disease With or Without Extraesophageal Symptoms

Guoping JİANG, Yanqun CONG, Feng ZHOU, Peifen ZHENG

Evaluation of Psychosocial Outcomes of Living Liver Donors in Liver Transplantation

Yaprak Sarıgöl ORDİN, Arzu Kader HARMANCI SEREN, Özgül KARAYURT, Gülay Aksu KUL, Murat KILIÇ, Cemal Ata BOZOKLAR, Yaman TOKAT

Monocyte/High-Density Lipoprotein Ratio Is an Indicator of Activity in Patients with Ulcerative Colitis

Mehmet Suat YALÇIN, Serkan YALAKİ, Şehmus ÖLMEZ, Adnan TAŞ

Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center

Sandro da Costa FERREİRA, Lilian Rose Otoboni APRİLE, Rog rio Serafim PARRA, Marley Ribeiro FEİTOSA, Gleici de Castro da Silva PERDON, Omar F RES, Jos Joaquim Ribeiro da ROCHA, Luiz Ernesto de Almeida TRONCON

Trimetazidine has Promising Preventive Effects on Experimental Chronic Pancreatitis Rat Model

Mustafa KAPLAN, Arif KARAKAYA, Alpaslan TANOĞLU, Muhammet YILDIRIM, Yeşim Önal TAŞTAN, Zafer ÇIRAK, Zafer KÜÇÜKODACI

Immune-Mediated Association Between Celiac Disease and Sensorineural Hearing Loss: A Systematic Narrative Review

Pietro De LUCA, Alfonso SCARPA, Massimo RALLİ, Domenico TASSONE, Claudia CASSANDRO, Matteo SİMONE

Treatment Adherence of Anti-TNF Drugs in the Patients with Inflammatory Bowel Disease: A Scale Development Stud